Navigation Links
Judge Reserves Judgment In Cancer Drug Case

A High Court judge has revealed that he will not give an immediate judgment with regard to Ann Marie Rogers, a breast cancer patient, concerning her case against the NHS refusing her the Herceptin drug treatment. //Justice Bean has revealed that the case is too important as it will have its impact on other breast cancer patients also, for an immediate judgment. There will be no case of undue delay either, according to him. The Herceptin drug reduces the possibility of the HER-2 form of cancer by 50%.

The Swindon Primary Care Trust (PCT) is reported to have refused the drug to Marie Rogers, and she has been compelled to borrow £5,000 to finance her treatment. She is reported to have come to a stage wherein she can no longer afford the treatment. The PCT is funding the treatment with the drug in early stage cancers only in exceptional cases, which is sought to be declared irrational, arbitrary, and unlawful by Ian Wise, who is representing Ms Rogers.

The annual cost of treating a patient with the Herceptin drug is £21,800. Ms Rogers stands a 57% chance of her ailment recurring after a period of 10 years, according to Ian Wise, and refusing to finance her treatment may result in fatal consequences, thus depriving her of her right to life.

The advocate for the PCT, Philip Havers contends that the drug is yet to be licensed for early stage breast cancer, nor has its safety and efficacy been certified by the National Institute for Clinical Excellence (NICE). The policy of the PCT is also in conformity with the guidance of the Health Secretary, according to him. The judge is seeking to decide if the exceptional circumstances criteria can be made use of in some early stage cancers. A judgment with regard to case is expected to be delivered in the second week of February 2006.
'"/>




Page: 1

Related medicine news :

1. Websites Are Judged In Less Than A Second
2. Patient’s Individual Cardiologist Best Judge For Deciding Appropriate Treatment In Chronic Coronary Artery Diseas
3. Judge bans veiled lawyers in courtrooms
4. Pigeon Feathers to Judge Pollution Levels
5. Marine Reserves Protect Coral Reefs
6. Hospital asked to Compensate Victim – Judgment by Delhi High Cour
7. Judgment In Favor Of Merck For Vioxx Drug
8. Life Or Death: Parents Await High Court Judgment
9. Italian Court Presides Over the Judgment of Incurably Ill Italian Man, Pleading Euthanasia
10. Fibroids unlikely to Turn Cancerous
11. Virus Level could Predict Cervical Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
(Date:6/25/2016)... ... 2016 , ... Experts from the American Institutes for Research ... June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR experts ... planning, healthcare costs and patient and family engagement. , AIR researchers will be ...
(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Any dentist who has made an implant ... process. Many of them do not even offer this as ... high laboratory costs involved. And those who ARE able to ... a high cost that the majority of today,s patients would ... Parsa Zadeh , founder of Dental Evolutions Inc. and inventor ...
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
(Date:6/23/2016)... 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... America . ... ... ... ...
Breaking Medicine Technology: